Meclozine dihydrochloride monohydrate is a first-generation antihistamine of the piperazine class primarily used to treat and prevent symptoms associated with motion sickness and vertigo. As a widely utilized… Read more
Meclozine dihydrochloride monohydrate is a first-generation antihistamine of the piperazine class primarily used to treat and prevent symptoms associated with motion sickness and vertigo. As a widely utilized active pharmaceutical ingredient, maintaining rigorous quality control standards is essential during its manufacturing and formulation. Analytical laboratories require high-quality reference standards of this compound to support impurity profiling and method validation, ensuring regulatory compliance and patient safety. This category encompasses the parent drug along with its related substances, including specific degradation products like meclozine N-oxide and N,N'-dioxide. Additionally, the inclusion of stable isotope-labelled compounds provides critical internal standards for accurate quantification using techniques such as mass spectrometry and high-performance liquid chromatography. Researchers and pharmaceutical chemists rely on these reference materials to detect, identify, and quantify impurities throughout the drug development and quality control lifecycle.